Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Cut to "Underweight" at Barclays

Key Points

• Barclays downgraded Fresenius Medical Care to “underweight” from “equal weight.” MarketBeat’s analyst consensus is “Reduce,” with an average price target of $23.42.
• The company’s latest quarter showed mixed results: earnings per share of $0.64 fell short of the $0.65 consensus, while revenue of $5.59 billion exceeded estimates of $5.52 billion.
• Shares opened at $23.39, within the stock’s 12-month range of $20.02 to $26.42.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS - Get Free Report) was downgraded by analysts at Barclays from an "equal weight" rating to an "underweight" rating in a research report issued on Monday, Marketbeat Ratings reports.

A number of other equities analysts have also recently weighed in on the stock. Sanford C. Bernstein upped their price objective on shares of Fresenius Medical Care AG & Co. KGaA from $25.50 to $25.80 and gave the company a "market perform" rating in a research report on Thursday, August 6th. Berenberg Bank set a $24.00 target price on Fresenius Medical Care AG & Co. KGaA in a research report on Tuesday, September 29th. Zacks Research cut Fresenius Medical Care AG & Co. KGaA from a "hold" rating to a "strong sell" rating in a research note on Thursday, October 15th. Citigroup reissued a "neutral" rating on shares of Fresenius Medical Care AG & Co. KGaA in a report on Friday, July 17th. Finally, Weiss Ratings upgraded Fresenius Medical Care AG & Co. KGaA from a "hold (c)" rating to a "hold (c+)" rating in a research note on Thursday, October 8th. Seven analysts have rated the stock with a Hold rating and five have issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Reduce" and an average price target of $23.42.

Fresenius Medical Care AG & Co. KGaA Price Performance

Shares of FMS stock opened at $23.39 on Monday. The company has a market capitalization of $12.45 billion, a PE ratio of 13.52, a price-to-earnings-growth ratio of 5.50 and a beta of 0.78. The firm has a fifty day simple moving average of $22.33 and a 200-day simple moving average of $22.90. The company has a current ratio of 0.99, a quick ratio of 0.69 and a debt-to-equity ratio of 0.37. Fresenius Medical Care AG & Co. KGaA has a twelve month low of $20.02 and a twelve month high of $26.42.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS - Get Free Report) last released its quarterly earnings results on Tuesday, November 3rd. The company reported $0.64 earnings per share for the quarter, missing analysts' consensus estimates of $0.65 by ($0.01). Fresenius Medical Care AG & Co. KGaA had a net margin of 4.23% and a return on equity of 9.08%. The firm had revenue of $5.59 billion for the quarter, compared to analyst estimates of $5.52 billion. Equities research analysts anticipate that Fresenius Medical Care AG & Co. KGaA will post 2.23 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. Tidal Investments LLC lifted its holdings in Fresenius Medical Care AG & Co. KGaA by 96.0% during the 2nd quarter. Tidal Investments LLC now owns 99,790 shares of the company's stock worth $2,256,000 after buying an additional 48,885 shares during the last quarter. Royal Bank of Canada grew its position in shares of Fresenius Medical Care AG & Co. KGaA by 479.2% in the 1st quarter. Royal Bank of Canada now owns 216,861 shares of the company's stock worth $4,893,000 after acquiring an additional 179,418 shares in the last quarter. Quantinno Capital Management LP grew its position in shares of Fresenius Medical Care AG & Co. KGaA by 15.7% in the 1st quarter. Quantinno Capital Management LP now owns 341,343 shares of the company's stock worth $7,701,000 after acquiring an additional 46,428 shares in the last quarter. Sei Investments Co. grew its position in shares of Fresenius Medical Care AG & Co. KGaA by 80.7% in the 1st quarter. Sei Investments Co. now owns 120,704 shares of the company's stock worth $2,723,000 after acquiring an additional 53,922 shares in the last quarter. Finally, Assetmark Inc. increased its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 190.7% in the 1st quarter. Assetmark Inc. now owns 132,320 shares of the company's stock valued at $2,985,000 after acquiring an additional 86,798 shares during the last quarter. 8.37% of the stock is owned by institutional investors and hedge funds.

Fresenius Medical Care AG & Co. KGaA Company Profile

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.